Thesis (Ph. D.)--University of Chicago, 1943. / Includes bibliographical references.

Class of 2011 Abstract / OBJECTIVES: To compare the use of propofol to dexmedetomidine hydrochloride (Precedex®) in patients undergoing pain pump placements at University Physicians Hospital. METHODS: A retrospective chart review was performed evaluating anesthesia charts from December 2009 through February 2011. Heart rate (HR), blood pressure (BP), respiratory rate (RR), surgery time, and length of stay in the PACU were collected for both treatment groups. Demographic variables were also collected including age, sex, medical condition for which they are having a procedure performed, other co-morbid conditions and concurrent medications. RESULTS: Charts were reviewed for 8 dexmedetomidine patients and 16 propofol patients. There was no statistical difference among the groups with regard to demographics. The groups had similar procedural average systolic blood pressures, diastolic blood pressures, and heart rate (p = 0.93; p = 0.56, p = 0.37 respectively). The procedure time and recovery time in the PACU were similar between the dexmedetomidine group and propofol group (p = 0.52; p = 0.25, respectively). The endpoint respiratory rate was significantly lower in the propofol group (p = 0.05). There was no difference in additional sedative-analgesic medication use. CONCLUSION: Dexmedetomidine does not offer any clinical advantages to propofol when used as anesthesia for pain pump placement.

This project was divided into two studies. The first investigated the pharmacokinetics of imipramine hydrochloride (IMI) in bulls. IMI was administered intravenously to three bulls (600-705.5 kg) at a dose of 2mg/kg body weight (BW). Intravenous plasma concentrations of IMI over time were determined by fluorescence polarization immunoassay (FPIA). IMI plasma concentration versus time profile was best described by a two compartmental open model with first-order rate constants. IMI distributed rapidly, (t½<font face="symbol">a</font>) at 7.2 ± 4.2 min, exhibited a very large apparent steady state volume of distribution (Vdss) of 4.2 ± 0.9 <font face="symbol">l</font>/kg BW, had a very short terminal elimination half-life (t½<font face="symbol">b</font>) of 140 ± 15 min and showed a rapid total body clearance (C<font face="symbol">l</font>) of 22.7 ± 7 m<font face="symbol">l</font>/min/kg. Both IMI and the pharmacologically active metabolite, desipramine was negligible in serum at 24 hours. All three bulls treated with IMI showed pronounced central nervous system signs immediately post injection. Signs of generalised weakness and ataxia were evident. All CNS signs dissipated 15-20 minutes post injection and should therefore not influence the treatment interval. An interval of at least 23 hours between repeat treatments of IMI, representing a period of at least 10 half-lives, is recommended. The dose of 2 mg/kg BW used in this study was similar to that routinely used in stallions without fatal side effects. One of the three bulls exhibited spontaneous emission and ejaculation with this dose. The second study investigated the effects of IMI on ampullar strips of bulls in organ baths. Vasa deferentia were collected from 16 freshly slaughtered post-puberal bulls of various breeds. Longitudinal ampullar strips were prepared and placed into 20 ml modified Krebs bicarbonate solution, aerated with a mixture of 02 (95 %) and CO2 (5 %) in water-jacketed organ baths. The effect on the smooth muscle tissue of noradrenaline (NA) alone, NA in combination with IMI and IMI alone was evaluated. NA alone consistently produced dose-dependant smooth muscle tissue contractions. IMI doses equivalent to <1 mg/kg BW (body weight equivalent; bwe) had NA potentiating effects. Doses of <0.1 mg/kg bwe were consistently potentiating while doses of >0.1 mg to <1 mg/kg bwe partially blocked NA stimulating effects. Amplitude of rhythmic contractions increased while contraction frequency decreased at this level. This study supports the adrenergic potentiating effects of IMI at doses of 0.05-0.2 mg/kg bwe with higher doses having paradoxical effects. Doses of IMI < 2 mg/kg bwe completely blocked NA effects. Tissue response to NA, after IMI blockade, started to recover 146-186 minutes after application of IMI at <2 mg/kg bwe. In the absence of NA, IMI had no effect on smooth muscle activity. The time to an IMI effect on NA initiated smooth muscle activity was 8 minutes. On the basis of the results of this in vitro study, we propose that IMI can be used to enhance semen collection by means of electro-stimulation in domestic bulls and immobilised wildlife species such as buffalo, provided that the correct dose is used. / Dissertation (MMedVet (Gyn))--University of Pretoria, 2005. / Production Animal Studies / unrestricted

Doctor of Philosophy / Department of Animal Sciences and Industry / James S. Drouillard / Beta-adrenergic agonists, which are synthetic catecholamines, increase rate of gain, improve feed efficiency, and decrease carcass fat, when fed to cattle before slaughter. However, little attention has been given to the potential effects of beta-adrenergic agonists on the rumen ecosystem. Natural catecholamines, such as norepinephrine, epinephrine, and dopamine, have been observed to stimulate bacterial growth. The objectives of this research were to determine if ractopamine hydrochloride (RAC) a synthetic catecholamine has direct effects on growth and fermentation products of ruminal bacteria, and to determine the effects of protein source on ruminal fermentation and proteolysis when cattle are fed RAC. The effects of varying concentrations of RAC on ruminal fermentation were evaluated in vitro. Ractopamine hydrochloride had a quadratic effect on in vitro gas production (P < 0.05). Total VFA production was not changed with RAC (P > 0.50). Different concentrations of RAC were evaluated in vitro with different nitrogen sources to determine effects of nitrogen degradability on response to RAC. There was an interaction between RAC and nitrogen substrate (P < 0.01), with more degradable forms of nitrogen eliciting greater changes in in vitro dry matter disappearance (IVDMD) with RAC supplementation. Significant main effects also were detected for RAC, substrate, and hour (P < 0.001). In vitro analysis of proteolysis revealed that RAC lowered ammonia and amino acid concentrations (P < 0.001). In vivo ruminal ammonia concentrations also were lower when RAC was fed in combination with dry-rolled corn, but not when fed in conjunction with steam-flaked corn (grain processing × RAC, P < 0.01). Addition of RAC, steam-flaked corn, and distiller’s grains (DG) all resulted in lower ruminal ammonia concentrations (P < 0.01). Amino acid concentrations were decreased when RAC was added to diets with DG but were unchanged in diets without added DG (DG × RAC, P < 0.05). Results from these studies suggest that RAC affects fermentation by ruminal microflora. However, there were no differences in growth or fermentative end products of pure bacterial cultures with the addition of RAC (P > 0.10). Overall beta-adrenergic agonists alter ruminal fermentation, which could have important implications for diet formulation.

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior / This study was carried out in three parts: At first, three methods for the bromination of 6-alkylsubstituted 2-phenyl-3H-pyrimidin-4-ones was developed for the synthesis of: (i) a new series of 6-alkylsubstituted 5-bromo-2-phenyl-3H-pyrimidin-4-ones, (ii) a new series of 6-(1-bromoalkyl)-2-phenyl-3H-pyrimidin-4-ones, and (iii) e new series of 5-bromo-6-(1-bromoalkyl)-2-phenyl-3H-pyrimidin-4-ones. On the second part, the brominated pyrimidines obtained, were used to synthesize new 6-methylsubstituted 2-phenyl-3Hpyrimidin-4-ones from the reaction of the brominated pyrimidinones with primary and secondary amines, pyridine and sodium azide. On the third part, a new series of 5- e 6-substituted 4-trifluoromethyl-2-ureido pyrimidines was prepared, in good yields, from the cyclocondensation reaction of β- alkoxyvinyl-trifluoromethylketones substituted and dicyanodiamide. The products synthesized in this study were obtained in good yields and were characterized by GC-MS and 1H e 13C RMN spectroscopy. The purity of the products was assured by elemental analysis. Some compounds such as 5-bromo-2-phenyl-6-propyl-3H-pyrimidin-4-one, 5-bromo-6-(1- bromopropyl)-2-phenyl-3H-pyrimidin-4-one, 5-bromo-6-(1-bromobutyl)-2-phenyl-3H-pyrimidin-4-one, 6-(1-azidoethyl)-5-bromo-2-phenyl-3H-pyrimidin-4-one, 6-(1-azidopropyl)-5-bromo-2-phenyl-3H-pyrimidin-4-one, and 6-(1-azidobutyl)-5-bromo-2-phenyl-3H-pyrimidin-4-one, exhibited significant antimicrobial activity against some microorganisms, such as Candida albicans, Saccharomyces cerevisiae, Staphylococcus aureus, Salmonela, Klebsiela pneumonie among others. / Este trabalho foi realizado em três etapas. Na primeira, foram desenvolvidos três métodos de bromação de 2-fenil-3H-pirimidin-4-onas 6-alquilsubstituídas para a obtenção de: (i) uma série inédita de 5-bromo-2-fenil-3H-pirimidin-4-onas 6-alquilsubstituídas, (ii) uma série inédita de 6-(1- bromoalquil)-2-fenil-3H-pirimidin-4-onas e (iii) uma série inédita de 5-bromo-6-(1-bromoalquil)-2-fenil-3H-pirimidin-4-onas. Na segunda etapa, as pirimidinas bromadas, obtidas na etapa anterior, foram utilizadas para sintetizar novas 2-fenil-3H-pirimidin-4-onas 6-metilsubstituídas através de reações das pirimidinonas bromadas com aminas primárias e secundárias, piridina e azida de sódio. Na terceira etapa, foi sintetizada uma nova série de 4-trifluormetil-2-ureído pirimidinas 5- e 6-substituídas a partir de reações de ciclocondensação entre -alcoxivinil-fluormetilcetonas substituídas e dicianodiamida. Os produtos sintetizados neste trabalho foram obtidos em bons rendimentos e foram caracterizados por CG-EM e RMN de 1H e 13C. A pureza dos produtos foi comprovada por análise elementar. Alguns compostos como 5-bromo-2-fenil-6-propil-3H-pirimidin-4-ona, 5-bromo-6-(1-bromopropil)-2-fenil-3H-pirimidin-4-ona, 5-bromo-6-(1-bromobutil)-2-fenil-3Hpirimidin-4-ona, 6-(1-azidoetil)-5-bromo-2-fenil-3H-pirimidin-4-ona, 6-(1- azidopropil)-5-bromo-2-fenil-3H-pirimidin-4-ona e 6-(1-azidobutil)-5-bromo-2-fenil-3H-pirimidin-4-ona, apresentaram atividade antimicrobiana significativa contra alguns microorganismos como Candida albicans, Saccharomyces cerevisiae, Staphylococcus aureus, Salmonela, Klebsiela pneumonie e outras.

Class of 2015 Abstract / Objectives: To assess the solubility and stability of tetracycline in compounded miracle mouthwash solutions over time, and at different temperatures (room temperature versus refrigerated) and pH (unaltered versus pH 7). Methods: Miracle mouthwash (MMW) solutions were compounded using tetracycline HCl capsules and 1:1 pseudo-dexamethasone elixir and diphenhydramine. High-performance liquid chromatography (HPLC) was used to measure the tetracycline concentrations in the MMW samples tested. Data on tetracycline crystal composition over time were also collected using powder x-ray diffraction, differential scanning calorimetry (DSC), and thermal gravimetric analysis (TGA). Results: For the tetracycline MMW solutions stored at room temperature, only 16% of the original tetracycline remained in solution after 24 hours, stabilizing at 65-81 mcg/mL on day 5 then decreasing further down to 45 mcg/mL by day 15. Similar results were obtained for the refrigerated tetracycline MMW solution (11% of original concentration after 5 days, with a decrease from 31-54 mcg/mL on day 5 to 22 mcg/mL on day 15). Tetracycline concentrations appeared to undergo a steeper decline in MMW solutions of pH 7 than in unadjusted MMW solutions (pH 4.68). All MMW samples exhibited a conversion from tetracycline HCl to tetracycline hexahydrate. Conclusions: Tetracycline solubility decreases rapidity in MMW within 24 hours of compounding regardless of temperature. MMW solutions at pH 7 may have further reduced solubility. Stability decreases at a stable rate from tetracycline HCl to tetracycline hexahydrate.

Development of cataracts is a relatively frequent ocular disease of the dog and cataract extraction via phacoemulsification (PE) is commonly performed by veterinary ophthalmologists. Postoperative ocular hypertension (POH) describes the elevation of pressures within the eye during the acute postoperative period and can result in vision loss and poor surgical outcome. Relatively little is known about risk factors or efficacy of prophylactic treatment for POH, and current clinical practice with regard to pressure monitoring and medication administration are highly variable. The literature on POH prophylaxis in humans indicates that improved efficacy may be achieved with a multi-dose approach and that dorzolamide hydrochloride/timolol maleate (DHTM) may be more efficacious than other pressure lowering medications. The canine literature on POH prophylaxis is limited and DHTM has not yet been evaluated despite common use in the clinical setting. Our objectives, therefore, were to investigate risk factors for POH and to test the hypothesis that perioperative topical ophthalmic dorzolamide hydrochloride 2%/timolol maleate 0.5% (DHTM) reduces the prevalence and/or severity of postoperative ocular hypertension (POH) in dogs undergoing cataract extraction by phacoemulsification (PE). We employed a randomized double-masked placebo-controlled study and enrolled 103 dogs (180 eyes) presenting for unilateral or bilateral PE. Select historical, signalment, ophthalmic examination, and surgical data was collected. Dogs were treated with DHTM or Blink Contacts (BC) placebo at 14- and 2-h preoperatively and at conclusion of surgical closure. Intraocular pressures were assessed by rebound tonometry at 2, 4, 6, and 8 hours after surgery and at 8 am the following morning. POH was defined as IOP>25 mmHg and intervention consisted of latanoprost 0.005% if IOP rose to 26 mmHg - 45 mmHg or surgeon treatment of choice if >45 mmHg. Our investigation of risk factors yielded a statistically significant association only with surgeon and surgical time, which were also associated with one another. DHTM significantly reduced the prevalence of POH in comparison with BC (26% versus 49% of eyes, OR=0.36; 34% versus 62% of dogs, OR=0.32). There was also a trend toward reduction of POH severity in DHTM-treated eyes (POH value 37.17±10.47 mmHg with BC, 32.67±6.39 mmHg with DHTM). DHTM-treated eyes that developed POH were significantly more likely to respond favorably (1 hour post-treatment IOP <25 mmHg) to treatment with latanoprost than those in the BC group (76% versus 51%, OR=3.87). We conclude that multi-dose perioperative administration of DHTM may be recommended in dogs undergoing PE to reduce the risk of POH and improve responsiveness of POH to treatment with latanoprost. / Master of Science

Since the surfaces of cantaloupes are highly rough or irregular, Salmonella enteric and other bacteria can easily attach to these surfaces and are difficult to remove. Cetylpyridinium chloride (CPC) is the active ingredient of some antiseptic oral mouth rinses and has a broad antimicrobial spectrum with a rapid bactericidal effect on Gram-positive pathogens. Delmopinol hydrochloride (delmopinol) is a cationic surfactant that is effective for treating and preventing gingivitis and periodontitis. The application of delmopinol or CPC to cantaloupe surfaces may be an alternative post harvest technique to reduce the frequency and level of Salmonella contamination. Cantaloupe (Athena and Hale's Best Jumbo (HBJ) cultivars) rind plugs were inoculated with a broth culture of Salmonella Michigan. After 15 min, plugs were sprayed with 10 ml of a 1% delmopinol solution, or a CPC solution (0.5 or 1.0%) or distilled water (Control), and held at 37 oC for 1 hr or 24 hr. For additional samples, the chemical treatments were applied 15 min before pathogen inoculation. Melon plugs were submerged in Butterfield's Phosphate Buffer, shaken, sonicated and solutions were enumerated on Tryptic Soy Agar. The texture quality and color of additional melon samples were evaluated after delmopinol or CPC spray treatments and storage at 4 oC. A 1.0% application of CPC reduced Salmonella levels up to 2.34 log CFU/ml (Athena) and 4.95 log CFU/ml (HBJ) in comparison to the control (p<0.01). A 1.0% delmopinol treatment reduced Salmonella levels as much as 3.1 log CFU/ml in comparison to the control (p<0.01) on both cultivars. In general, the log recovery of Salmonella on cantaloupes treated with delmopinol or CPC solutions, after 1 hr storage, was significantly lower (p<0.05) than the recovery from control cantaloupes, but Salmonella recovery was not significantly different after 24 hr. No significant differences were observed in the texture and color of melons treated with delmopinol or CPC after 14 days. A surface spray application of delmopinol hydrochloride or cetylpyridinium chloride could be an alternative antimicrobial post-harvest treatment that could make cantaloupes surfaces more susceptible to sanitizers or enhance physical removal of bacteria. / Ph. D.

M.S.

No contexto de qualidade, segurança e eficácia dos medicamentos, os produtos de degradação surgem com um crescente foco regulatório no Brasil e no mundo. Para análise confiável dos medicamentos, métodos indicativos de estabilidade devem ser utilizados, visando a avaliação qualitativa e quantitativa das impurezas e dos produtos de degradação neles contidos. O cloridrato de propafenona é utilizado no tratamento de arritmias supraventriculares e ventriculares, apresentando-se como bloqueadores dos canais de sódio, além de ser um betabloqueador. O cloridrato de pioglitazona é um agente anti-hiperglicemiante que atua primariamente diminuindo a resistência à insulina, no tratamento da Diabetes tipo 2. Os métodos oficiais descritos nas farmacopeias, muitas vezes, não fornecem informações a respeito de análise de impurezas farmacêuticas e de produtos de degradação. Assim sendo, deve-se verificar se os métodos são indicativos da estabilidade, antes de utilizá-los para analisar os produtos de degradação. A presente pesquisa tem como objetivo avaliar amostras simuladas dos medicamentos citados, após serem submetidos a condições de estresse; determinar os principais produtos de degradação através dos métodos descritos na Farmacopeia Americana e avaliar se tais métodos são indicativos de estabilidade, assim como realizar balanço de massa. Foi realizado um delineamento fatorial 32 dos meios de degradação avaliando-se a variação do tempo e da intensidade e a capacidade de detecção e quantificação de produtos de degradação presentes. Os fatores considerados no delineamento foram degradação ácida, alcalina, meio oxidativo com peróxido de hidrogênio, e temperatura/umidade além da fotoestabilidade. O cloridrato de propafenona apresentou degradação nos estresses ácidos, oxidativos e em temperatura/umidade. No meio alcalino e a exposição a luz (branca/UV), a magnitude da degradação foi amena. Houve um balanço de massas entre os métodos de doseamento e de impurezas, mostrando-se que o método é indicativo de estabilidade. O principal produto de degradação, no meio ácido e oxidativo, foi identificado utilizando o método de LC-MS. O cloridrato de pioglitazona apresentou degradação em meios básicos, oxidativos assim como em exposição à luz e elevada temperatura/umidade. A hidrólise ácida não apresentou impacto significativo. Os métodos de doseamento e de impurezas não apresentaram balanço de massa, mostrando-se que o método não é indicativo de estabilidade. As análises in silico, com o software Zeneth®, foi utilizada para estabelecer correlações entre o processo de degradação e os plausíveis produtos formados. Assim, conclui-se que os dados de estresses obtidos, neste trabalho, podem servir como suporte nos estudos de estabilidade, bem como contribuir na definição das condições de transporte e armazenamento do cloridrato de propafenona e cloridrato de pioglitazona. / In the context of quality, safety and efficacy of pharmaceuticals, degradation products ascend with a growing regulatory focus in Brazil and in the world. For reliable analysis of pharmaceutical products, stability indicative methods must be used, aiming at qualitative and quantitative analysis of impurities and degradation products contained therein. Propafenone HCl is used in the treatment of supraventricular and ventricular arrhythmias and has sodium channel blocking capacity, besides its betareceptor blocking activity. Pioglitazone HCl is an anti-hiperglicemiante agent that acts primarily by reducing insulin resistance in the treatment of type 2 diabetes. The official methods described in the Pharmacopoeias often do not provide information regarding the analysis of pharmaceutical impurities and degradation products. Therefore, it important to verified whether the methods are stability indicative or not, before being use in the analysis of degradation products. The objective of this research is to evaluate simulated samples of cited pharmaceuticals, after submission to stress conditions. To determine the main degradation products through the methods described in the American Pharmacopoeia and assess whether such methods are indicative of stability by mass balance approach. A factorial design (32) of the degradation mediums was carried out to evaluate impact of time of contact and variable intensity. On the outer side, the ability of the method to detect and quantify degradation products was also assessed. The degradation medium factors considered in the design were, acid, alkaline, oxidant medium using hydrogen peroxide, temperature/humidity and photostability. Propafenone hydrochloride presented degradation in acid, oxidative and temperature/humidity stress conditions. In the alkaline medium and exposure to light (white/UV), the extent of degradation was mild. There was a mass balance between the assay method and impurity method, illustrating that the method is stability indicative. The main degradation product, in the acidic and oxidative medium, was identified using the LC-MS method. Pioglitazone hydrochloride presented degradation in basic, oxidative means as well as on exposure to light and elevated temperature/humidity conditions. Acidic hydrolysis has no significant impact. The assay and impurity methods did not show mass balance, elucidating that the method is not stability indicative. In silico analysis, with the Zeneth® software, was used to establish correlations between the degradation process and the plausible degradation pathway and products. Thus, it is concluded that the data obtained in degradation studies, in this work, may serve as support in the stability studies, as well as subsidize to define transport and storage conditions for propafenone HCl and pioglitazone HCl.